Enzymes of the L-arginine to nitric oxide pathway

被引:160
|
作者
Stuehr, DJ [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA
来源
JOURNAL OF NUTRITION | 2004年 / 134卷 / 10期
关键词
L-arginine; nitric oxide; flavoprotein; reactive oxygen species; hemeprotein;
D O I
10.1093/jn/134.10.2748S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
L-Arginine is the biological precursor of nitric oxide (NO), which serves as an important signal and effector molecule in animals. This review summarizes some structure-function aspects of the mammalian nitric oxide synthases, which are enzymes that catalyze the oxidation Of L-arginine to NO and L-citrulline. These include aspects related to: 1) the chemical transformations Of L-arginine during enzyme catalysis, 2) binding of L-arginine or its structural analogs to the nitric oxide synthases, and 3) how L-arginine levels may affect product formation by the nitric oxide synthases and how this can be modulated by structural analogs of L-arginine.
引用
收藏
页码:2748S / 2751S
页数:4
相关论文
共 50 条
  • [31] Use of L-arginine and its analogs to study nitric oxide pathway in humans
    Vallance, P
    NITRIC OXIDE, PT B: PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES, 1996, 269 : 453 - 459
  • [32] Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells
    Wyatt, AW
    Steinert, JR
    Mann, GE
    FREE RADICALS: ENZYMOLOGY, SIGNALLING AND DISEASE, 2004, 71 : 143 - 156
  • [33] THE L-ARGININE NITRIC-OXIDE PATHWAY - BIOLOGICAL PROPERTIES AND THERAPEUTIC APPLICATIONS
    NEILLY, PJD
    KIRK, SJ
    GARDINER, KR
    ROWLANDS, BJ
    ULSTER MEDICAL JOURNAL, 1994, 63 (02): : 193 - 200
  • [34] The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury
    Pernow, J
    Wang, QD
    ACTA PHYSIOLOGICA SCANDINAVICA, 1999, 167 (02): : 151 - 159
  • [35] Impairment in the L-arginine nitric oxide pathway in patients with secondary arterial hypertension
    Mattei, P
    Virdis, A
    Ghiadoni, L
    Arzilli, F
    Bernini, G
    Taddei, S
    Salvetti, A
    JOURNAL OF HYPERTENSION, 1998, 16 : S86 - S86
  • [36] Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
    G. M. Pieper
    W. Siebeneich
    G. Moore-Hilton
    A. M. Roza
    Diabetologia, 1997, 40 : 910 - 915
  • [37] Reversal by L-arginine of a dysfunctional arginine nitric oxide pathway in the endothelium of the genetic diabetic BB rat
    Pieper, GM
    Siebeneich, W
    MooreHilton, G
    Roza, AM
    DIABETOLOGIA, 1997, 40 (08) : 910 - 915
  • [38] Altered activation of the L-arginine nitric oxide pathway during and after cardiopulmonary bypass
    Duke, Trevor
    South, Mike
    Stewart, Alastair
    PERFUSION-UK, 1997, 12 (06): : 405 - 410
  • [39] Effect of L-arginine and ACE inhibitors on nitric oxide/cGMP pathway in spontaneous hypertension
    Pechanova, O
    Bernatova, I
    JOURNAL OF HYPERTENSION, 2002, 20 : S384 - S385
  • [40] The effect of serum on the L-arginine nitric oxide metabolic pathway in mesangial cells.
    Doi, SO
    Jacot, TT
    Donald, C
    Striker, LJ
    Hirszel, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0405 - A0405